ANTHONY CARTER: Open Payments
NPI 1104890276 · TOMPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 30 payments from 11 companies in 2025. Trend: 2023 $913 · 2024 $818 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Corcept Therapeutics | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Indivior Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, UBRELVY, Korlym, HETLIOZ, GVOKE HYPOPEN, Veozah, ELIQUIS.
Industry payments across KY — which companies pay providers there.
